BioScience Health Innovations, Inc.
BHIC
$4.13
-$0.05-1.20%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -52.26% | 39.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -52.26% | 39.01% | |||
| Cost of Revenue | -73.48% | 131.05% | |||
| Gross Profit | -15.09% | -18.09% | |||
| SG&A Expenses | -1.78% | 3.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -43.28% | 51.68% | |||
| Operating Income | -46.71% | -1,680.68% | |||
| Income Before Tax | -46.71% | -1,680.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.58% | -2,554.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.58% | -2,554.55% | |||
| EBIT | -46.71% | -1,680.68% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 5.16% | -2,562.50% | |||
| Normalized Basic EPS | -41.57% | -1,680.00% | |||
| EPS Diluted | 5.16% | -2,562.50% | |||
| Normalized Diluted EPS | -41.57% | -1,680.00% | |||
| Average Basic Shares Outstanding | 3.62% | 0.00% | |||
| Average Diluted Shares Outstanding | 3.62% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||